Bioprocess International sponsored by Roche CustomBiotech
Follow Nobel laureate Katalin Karikó, Dennis C. Liotta, and IP advocate Joseph P. Allen as they share insights on translating innovative pharmaceutical modalities from research to commercialization.
mRNA and NRTIs represent two of today's most discussed pharmaceutical modalities. The former drug class has become a household name because of its critical role in ameliorating the COVID-19 pandemic. NRTIs gained importance as small molecule drug in HIV/AIDS treatment.